Clinical trial
Arnuity Ellipta Drug Use Investigation
NCT03184480 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Arnuity Ellipta Drug Use Investigation
- Lead sponsor
- GlaxoSmithKline
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 19, 2017
- Completion date
- March 17, 2021
- Enrollment
- 336 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.